Abstract
BackgroundThis study aimed to construct and assess a comprehensive model that integrates MRI-derived deep learning radiomics, functional imaging (fMRI), and clinical indicators to predict early efficacy of radiotherapy in nasopharyngeal carcinoma (NPC). MethodsThis retrospective study recruited NPC patients with radiotherapy from two Chinese hospitals between October 2018 and July 2022, divided into a training set (hospital I, 194 cases), an internal validation set (hospital I, 82 cases), and an external validation set (hospital II, 40 cases). We extracted 3404 radiomic features and 2048 deep learning characteristics from MRI modalities - T1WI, CE-T1WI, T2WI, and T2WI/FS. Additionally, both the ADC and its maximum (ADCmax) from DWI imaging, along with TBF and its maximum (TBFmax) from ASL imaging were derived. We used four classifiers (LR, XGBoost, SVM and KNN) and stacked algorithm as model construction methods. The receiver operating characteristic (ROC) curve (AUC) and decision curve analysis (DCA) was used to assess models. ResultsThe manual radiomics model leveraging XGBoost and the deep learning model based on KNN (the AUCs in the training set: 0.909, 0.823, respectively) showed better predictive efficacy than other machine learning algorithms. The stacked model that integrated MRI-based deep learning radiomics, fMRI, and hematological indicators, has a large improvement of AUC in the training set [0.984 (95%CI: 0.972 - 0.996)], the internal validation set [0.936 (95%CI: 0.885 - 0.987)], and the external validation set [0.959 (95%CI: 0.901-1)]. ConclusionsOur research has developed a clinical-radiomics integrated model based on MRI which can predict early radiotherapy response in NPC and provide guidance for personalized treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.